Sphingolipids From Pathology to Therapeutic Perspectives - A Themed Honorary Issue to Prof. Lina Obeid


English[eng]

9783040000000


S1P receptor||inflammation||S1P transporter||spinster homolog 2||barrier dysfunction||anxiety||depression||sphingolipids||sphingomyelinase||ceramidase||Smpd1||acid sphingomyelinase||forebrain||depressive-like behavior||anxiety-like behavior||ceramide||ceramides||ceramidases||neurodegenerative diseases||infectious diseases||sphingosine 1-phoshate||sphingosine 1-phosphate receptor||S1P1–5||sphingosine 1-phosphate metabolism||sphingosine 1-phosphate antagonistst/inhibitors||sphingosine 1-phosphate signaling||stroke||multiple sclerosis||neurodegeneration||fingolimod||Sphingosine-1-phosphate||obesity||type 2 diabetes||insulin resistance||pancreatic β cell fate||hypothalamus||sphingosine-1-phosphate||ischemia/reperfusion||cardioprotection||vasoconstriction||coronary flow||myocardial function||myocardial infarct||albumin||type 1 diabetes||beta-cells||islets||insulin||cytokines||S1P||animal models||cystic fibrosis||autophagy||myriocin||Aspergillus fumigatus||CLN3 disease||Cln3Δex7/8 mice||flupirtine||allyl carbamate derivative||apoptosis||cancer||gangliosides||immunotherapy||metastasis||phenotype switching||sphingosine 1-phosphate||Sphingosine 1-phosphate (S1P)||S1P-lyase (SGPL1)||tau||calcium||histone acetylation||hippocampus||cortex||astrocytes||neurons||sphingosine kinase||G-protein-coupled receptors||Gαq/11||n/a||sphingosine kinase 1||SK1||microRNA||transcription factor||hypoxia||long non-coding RNA